{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Blue Water Acquisition Corp. III"},"Symbol":{"label":"Symbol","value":"BLUWW"},"Address":{"label":"Address","value":"15 E. PUTNAM AVENUE,SUITE 363, GREENWICH, Connecticut, 06830, United States"},"Phone":{"label":"Phone","value":"+1 646 303-0737"},"Industry":{"label":"Industry","value":null},"Sector":{"label":"Sector","value":null},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Clarus Therapeutics, Inc. is a men's specialty pharmaceutical company with a mission to help men with hypogonadism, a condition associated with a deficiency or absence of endogenous testosterone. We are working hard every day to make a difference in the lives of affected men. As a privately-held company, Clarus Therapeutics is backed by Thomas, McNerney & Partners, L.P., H.I.G. BioHealth Partners, ProQuest Investments, C-Bridge Capital Partners, LLC, BVCF Management, Ltd. and Pavilion Capital Pte Ltd. To learn more, visit clarustherapeutics.com."},"CompanyUrl":{"label":"Company Url","value":null}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}